Leukaemia (chronic lymphocytic, relapsed) - rituximab: Appendix B - proposal paper presented to the Institute's Guidance Executive
|
Leukaemia (chronic lymphocytic, relapsed) - rituximab: Appendix B - proposal paper presented to the Institute's Guidance Executive
20 January 2014 (446.11 Kb 9 sec) |
This page was last updated: 14 January 2014